Antibacterial activity of plant-derived product against avian pathogenic Escherichia coli isolated from laying hens with colibacillosis: Influence of resistance profiles, synergy assessment, and validation in complex biological matrices

In the world of animal farming, bacteria are a constant threat. When these microscopic invaders cause disease, farmers often turn to antibiotics to save their flocks. However, overusing these medicines has led to a growing problem: bacteria are learning to fight back, becoming resistant to the drugs meant to kill them. This resistance is a serious concern not just for animal health, but for human health as well, as resistant bacteria can spread through the food chain. Because of this, scientists are searching for new ways to manage infections that do not rely on traditional antibiotics. One promising avenue involves using compounds found in nature, such as the oils and extracts from plants like cinnamon, oregano, and pomegranate. These natural substances have long been known to have antimicrobial properties, but their effectiveness against specific, hard-to-treat bacteria in real-world farming conditions has not been fully understood.

A team of researchers at the Université de Montréal set out to test a commercial plant-based product designed to fight a specific type of bacteria called avian pathogenic Escherichia coli, or APEC. This bacteria causes a disease known as colibacillosis in laying hens, leading to significant egg production losses and bird mortality. The scientists wanted to know if this plant-derived mixture could kill the bacteria found in sick hens, even if those bacteria had developed resistance to common antibiotics. They also wanted to see how the product performed in a messy, complex environment similar to a hen's gut, rather than just in a clean laboratory dish. Finally, they investigated whether the different ingredients in the product worked better together than they did alone, looking for a cooperative effect that might make the treatment more powerful.

To begin, the researchers gathered sixteen different strains of the disease-causing bacteria from laying hens that had been diagnosed with colibacillosis. They carefully analyzed these bacteria to understand their resistance profiles, checking which standard antibiotics they could survive. They found that many of the bacteria were indeed resistant to several common drugs, particularly those in the aminoglycoside and tetracycline families, with some strains resisting up to three different classes of antibiotics. Despite this diversity in resistance, the team tested the commercial plant product against all sixteen strains in a simple, controlled liquid culture. The results were consistent: the product stopped the growth of every single bacterial strain tested. The amount of product needed to halt the bacteria was the same for the resistant strains as it was for a standard, non-resistant laboratory strain. This suggested that the bacteria's ability to resist antibiotics did not help them resist this plant-based treatment.

The researchers then took the experiment a step further to see how the product would hold up in a more realistic setting. They created a complex biological matrix using the actual contents of a laying hen's cecum, a part of the digestive tract teeming with diverse microbes. They mixed this with the bacteria and the plant product to simulate what would happen inside a living bird. In this crowded, complex environment, the product was slightly less effective, requiring a higher concentration to stop the bacteria compared to the clean liquid culture. However, it remained effective against all the tested strains. This small drop in performance is likely because the fats and proteins in the cecal contents interacted with the plant compounds, making them slightly less available to attack the bacteria, but the product still worked.

To understand which parts of the mixture were doing the heavy lifting, the team tested the individual ingredients separately. The main components included essential oils from cinnamon, oregano, and clove, along with an extract from pomegranate. When tested on their own, the oils from cinnamon and oregano were the most powerful, stopping bacterial growth at lower concentrations than the clove oil or the pomegranate extract. The researchers then mixed these ingredients in pairs to see if they would boost each other's power. They found that while the combinations did not create a dramatic "super-power" effect where the whole became much greater than the sum of its parts, they also did not cancel each other out. Some mixtures, particularly cinnamon combined with pomegranate, showed a modest cooperative effect, but overall, the ingredients worked independently rather than synergistically.

The study concludes that this plant-derived product is a viable candidate for managing antibiotic-resistant bacteria in laying hens. It worked consistently against a wide variety of bacterial strains, regardless of their resistance to traditional drugs, and maintained its activity even in the complex environment of the bird's gut. While the product was slightly less potent in the presence of gut contents, it remained effective. The research suggests that the strong performance comes largely from the cinnamon and oregano oils, which appear to be the primary drivers of the antibacterial activity. Although the study did not find a magical synergy between the ingredients, it confirmed that the formulation is robust and not easily defeated by the bacteria's resistance mechanisms. The authors note that while these laboratory results are encouraging, the next step is to test the product in live hens to confirm it can prevent disease and improve egg production without harming the birds or the quality of the eggs.